Here are 17 key notes on orthopedic and spine device companies over the past week.
Medtronic completed its second tranche investment in Mazor Robotics.
SeaSpine signed a definitive agreement to acquire NLT Spine, an Israel-based medical device company creating minimally invasive spine surgery products.
Zimmer Biomet is acquiring CD Diagnostics, a company developing immunoassays and biomarker testing.
The Advanced Medical Technology Association, along with large device company Johnson & Johnson, are asking the FDA to further explain the regulatory approach of additive manufacturing, which includes 3D printing.
Stryker's director, Ronda Stryker, sold about 12,000 company shares with a market value of $1.378 million.
The FDA cleared Spinal Elements' interspinous process device.
Spinal Simplicity introduced a new generation of the Minuteman G3 fusion device with FDA-cleared coating of hydroxyapatite.
A Reportstack report found both Zimmer Biomet and DePuy Synthes are two major companies in the European large joint orthopedic devices market.
RTI Surgical's CEO Brian Hutchison plans to retire.
Titan Spine extended its distribution agreement with MBA, an international medical device marketing-and-distribution organization, to offer the Endoskeleton titanium implants in Italy.
InVivo Therapeutics added Chicago-based Northwestern Medicine as a clinical site for its INSPIRE study.
Orthogrid Systems offers the HipGrid Drone technology, which assist practices performing outpatient procedures.
NovaBone Products received the Brazilian ANVISA Good Manufacturing Practices medical device certificate.
Paul Favorito, MD, of Mercy Health, Cincinnati, has published a paper in the Journal of Shoulder and Elbow Surgery about the use of DePuy Synthes' stepped socket in shoulder replacement surgery.
The Orthopaedic Implant Company launched its Antegrade/Retrograde Intramedullary Femur Nail System, which treats femoral midshaft and distal fractures.
The Orange County Technology Alliance named Vertos Medical a finalist in its Medical Technology category for the company's mild procedure.
Rotation Medical, a device company focused on developing technology to treat rotator cuff disease, secured $12 million in Series B extension financing.